METUCHEN, N.J.–(BUSINESS WIRE)– Tevogen Bio, a clinical stage biotechnology company specializing in immunotherapies, today announced that the U.S. Patent and Trademark
Read MoreThe Department of Justice announced today that it is requesting public comment on a new draft policy statement concerning standards-essential patents (SEPs)
Read MoreThe USPTO recently released its FY 2021 Performance and Accountability Report, which contains detailed information about allowance rates, average pendency, and
Read MoreThe US Court of Appeals for the Federal Circuit found that a license agreement between two parties required an arbitrator
Read MoreThe US Patent and Trademark Office (PTO) recently published its final rules implementing provisions of the Trademark Modernization Act of
Read More